about
Mechanism of Action of Atypical Antipsychotic Drugs and the Neurobiology of SchizophreniaSubanesthetic dose of ketamine decreases prefrontal theta cordance in healthy volunteers: implications for antidepressant effectLadislav Haskovec and akathisia: 100th anniversary.Treatment of acute agitation in psychotic disorders.Psychiatry in selected countries of Central and Eastern Europe: an overview of the current situation.Quality of life in the long-term treatment and the role of second-generation antipsychotics.Deep brain stimulation in psychiatry.The application of vagus nerve stimulation and deep brain stimulation in depression.Vitamin D in anxiety and affective disorders.Experience of stigma and discrimination reported by people experiencing the first episode of schizophrenia and those with a first episode of depression: The FEDORA project.Effectiveness of the information technology-aided program of relapse prevention in schizophrenia (ITAREPS): a randomized, controlled, double-blind study.Circulating C19 steroids and progesterone metabolites in women with acute depression and anxiety disorders.White matter changes in first episode psychosis and their relation to the size of sample studied: a DTI study.Long-acting injectable antipsychotics for prevention and management of violent behaviour in psychotic patients.Determination of steroid metabolome as a possible tool for laboratory diagnosis of schizophrenia.Individualized rTMS neuronavigated according to regional brain metabolism ((18)FGD PET) has better treatment effects on auditory hallucinations than standard positioning of rTMS: a double-blind, sham-controlled study.LORETA functional imaging in antipsychotic-naive and olanzapine-, clozapine- and risperidone-treated patients with schizophrenia.The role of steroids in the prediction of affective disorders in adult men.Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing-study on P300 and mismatch negativity in healthy volunteers.A Review of the Epidemiology of Major Depressive Disorder and of its consequences for Society and the individual.The steroid metabolome in men with mood and anxiety disorders.Effect of low-frequency rTMS on electromagnetic tomography (LORETA) and regional brain metabolism (PET) in schizophrenia patients with auditory hallucinations.Sedative effects of low-dose risperidone in GAD patients and risk of drug interactions.Myth and reality of pragmatic trials.Prolactin response to D-fenfluramine challenge test as a predictor of treatment response to haloperidol in acute schizophrenia.Low-dose risperidone augmentation of antidepressants or anxiolytics is associated with hyperprolactinemia.Neuro- and immunomodulatory steroids and other biochemical markers in drug-naive schizophrenia patients and the effect of treatment with atypical antipsychotics.Teaching critical appraisal of articles on psychopharmacology.Rhythmic finger-tapping task and fast segmentation of neural processing in schizophrenics.Subject selection for the placebo- and comparator-controlled trials of neuroleptics in schizophrenia.High-dose treatment with haloperidol: the effect of dose reduction.Effects of haloperidol treatment on prolactin response to D -fenfluramine challenge in acute schizophreniaThe influence of polymorphism for Serotonin 5HT-1A receptor on phenotypic variables in schizophreniaUpdated European Consensus Statement on diagnosis and treatment of adult ADHDValue of schizophrenia treatment I: The patient journeyValue of schizophrenia treatment II: Decision modelling for developing early detection and early intervention services in the Czech RepublicThe double-blind sham-controlled study of high-frequency rTMS (20 Hz) for negative symptoms in schizophrenia: negative resultsAssociation between catechol O-methyltransferase genotype and violence in schizophrenia and schizoaffective disorderPsychopathy and violent behavior among patients with schizophrenia or schizoaffective disorderRepetitive transcranial magnetic stimulation (rTMS) in major depressive episode during pregnancy
P50
Q22241430-D4188356-724E-483C-B5F5-D237903A1096Q28267032-83458A3F-FDF1-49A4-99DC-35C678B23590Q34529380-D6AD79BF-F4C5-45F8-B12D-AA04D57C478EQ36246320-269EC5EA-7C9C-4C5B-AC61-07FA93C26C58Q36591660-099783A3-0EE6-4171-92B7-73448B37945BQ36721909-BB3E1CC5-1AE2-4504-BD27-3043FC643111Q37333577-95188C2C-0A4F-46A1-BBA4-C8F10A876BA4Q37910667-D8655545-FC96-47EC-A4C9-B3A8D1058AE2Q38672845-DB59F6BD-5B0E-4540-AFBA-2BE7B489F326Q39116539-294D6548-A79E-43A4-87F4-BFEC6FC70E81Q39584561-4134C916-3491-4CB7-93AF-F97A04907854Q39840182-36A5F35E-D8B0-43D2-8B8E-40ABDDA4A1F6Q41466621-ABA389C0-6DC0-4CE9-B138-2EE18077D03FQ42687636-A5C4BDC2-4629-482A-A490-8C95DC925B8DQ44733763-BF0BAB7F-B36E-4E12-8776-8BE40AF5466CQ46111561-75F6DBBB-38AB-4559-B268-E474244C007DQ46379158-E0EFC4B4-94D7-4778-88EC-C52AA81C9924Q47362221-CE8C79F1-F820-4030-850F-FB70DEF7AAAFQ47558692-E26340EC-33A1-4525-887E-9B5C7B58CA2EQ47612229-1D583FFD-B9A8-41B9-9A36-9523E51A72EEQ48068261-6089C4E4-BEFB-4925-BC13-8C96B7C07F48Q48100045-C9BD0AAE-39A6-432F-929F-96FCEAF1EB94Q48490673-F20223D7-1F9F-4FC9-A5E4-FC15551DC451Q48857784-604E26CC-47AA-4B50-A619-B646DA97F08FQ50896516-7B57D98E-3628-44C3-B466-2E71235C8E43Q50914892-9B91D893-80F0-4C1F-8D31-C1E8BA3CE485Q51466633-926A0F48-D656-46D4-9BB8-2A35109A2DB5Q51790174-8276274A-2E2E-4D83-980A-41C229054B51Q52005620-6F77CAA6-E6F3-4F79-869F-2A98F4BF8E80Q52921131-606F95D4-599F-4F6E-BB7B-02AEB86E7FE6Q52921137-BCB57CEF-EE81-470D-98F3-B2607B1108C2Q60491843-F7D5673B-6649-46BF-9BD2-A078BAE77718Q60636069-A0D96420-001C-4D01-A14B-1708F6C64D9DQ60636990-FF96D902-03C6-4565-9311-8F81F4E354DAQ60642709-6C4EB5C3-2071-4392-9804-D6C3E75C13CFQ60642710-6AAD7C2C-A8CC-4641-BFCC-3F49249FA703Q62673946-B5F24FEB-21AE-494F-9934-8DB488A01656Q74626976-C283ECB6-F87C-4963-B3A4-E1BB2611C16CQ77900512-12D28278-49BF-49C5-9FE5-1BE669082809Q80727606-4D9C4F56-828B-4227-9BFF-7683DAEA5891
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Pavel Mohr
@ast
Pavel Mohr
@en
Pavel Mohr
@es
Pavel Mohr
@nl
Pavel Mohr
@sl
type
label
Pavel Mohr
@ast
Pavel Mohr
@en
Pavel Mohr
@es
Pavel Mohr
@nl
Pavel Mohr
@sl
prefLabel
Pavel Mohr
@ast
Pavel Mohr
@en
Pavel Mohr
@es
Pavel Mohr
@nl
Pavel Mohr
@sl
P214
P1053
R-3020-2016
P106
P1153
7102201936
P21
P214
P31
P3829
P496
0000-0002-9851-3271
P734
P735
P7859
viaf-305703784